In the MR1-/- mouse model, recipient MAIT cells were found to have the ability to inhibit alloantigen presentation by donor dendritic cells (DCs) and the subsequent expansion of effector T cells following transplantation, culminating in the attenuation of GVHD (51). The gene discussed is MR1; the disease is graft versus host disease.